<?xml version="1.0" ?>
<akomaNtoso xmlns="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <act name="section">
    <meta>
      <identification source="#wa-legislature">
        <FRBRWork>
          <FRBRthis value="/us-wa/act/rcw/74.09.640"/>
          <FRBRuri value="/us-wa/act/rcw/74.09.640"/>
          <FRBRdate date="2025-12-31" name="enacted"/>
          <FRBRauthor href="#wa-legislature"/>
          <FRBRcountry value="us-wa"/>
        </FRBRWork>
        <FRBRExpression>
          <FRBRthis value="/us-wa/act/rcw/74.09.640/eng"/>
          <FRBRuri value="/us-wa/act/rcw/74.09.640/eng"/>
          <FRBRdate date="2025-12-31" name="publication"/>
          <FRBRauthor href="#wa-legislature"/>
          <FRBRlanguage language="eng"/>
        </FRBRExpression>
        <FRBRManifestation>
          <FRBRthis value="/us-wa/act/rcw/74.09.640/eng/akn"/>
          <FRBRuri value="/us-wa/act/rcw/74.09.640/eng/akn"/>
          <FRBRdate date="2025-12-31" name="generation"/>
          <FRBRauthor href="#cosilico"/>
        </FRBRManifestation>
      </identification>
      <references source="#cosilico">
        <TLCOrganization eId="wa-legislature" href="/ontology/organization/us-wa/legislature" showAs="Washington State Legislature"/>
        <TLCOrganization eId="cosilico" href="https://cosilico.ai" showAs="Cosilico"/>
      </references>
    </meta>
    <body>
      <section eId="sec_74_09_640">
        <num>RCW 74.09.640</num>
        <heading>Opioid use disorder—Nonpharmacologic treatments</heading>
        <subsection eId="sec_74_09_640__subsec_1">
          <num>(1)</num>
          <content>
            <p>In order to support prevention of potential opioid use disorders, the authority must develop and recommend for coverage nonpharmacologic treatments for acute, subacute, and chronic noncancer pain and must report to the governor and the appropriate committees of the legislature, including any requests for funding necessary to implement the recommendations under this section. The recommendations must contain the following elements:</p>
          </content>
          <subsection eId="sec_74_09_640__subsec_1__subsec_a">
            <num>(a)</num>
            <content>
              <p>A list of which nonpharmacologic treatments will be covered;</p>
            </content>
          </subsection>
          <subsection eId="sec_74_09_640__subsec_1__subsec_b">
            <num>(b)</num>
            <content>
              <p>Recommendations as to the duration, amount, and type of treatment eligible for coverage;</p>
            </content>
          </subsection>
          <subsection eId="sec_74_09_640__subsec_1__subsec_c">
            <num>(c)</num>
            <content>
              <p>Guidance on the type of providers eligible to provide these treatments; and</p>
            </content>
          </subsection>
          <subsection eId="sec_74_09_640__subsec_1__subsec_d">
            <num>(d)</num>
            <content>
              <p>Recommendations regarding the need to add any provider types to the list of currently eligible medicaid provider types.</p>
            </content>
          </subsection>
        </subsection>
        <subsection eId="sec_74_09_640__subsec_2">
          <num>(2)</num>
          <content>
            <p>The authority must ensure only treatments that are evidence-based for the treatment of the specific acute, subacute, and chronic pain conditions will be eligible for coverage recommendations.
[
2019 c 314 s 35
.]
NOTES:
Declaration
—
2019 c 314:
See note following RCW
18.22.810
.</p>
          </content>
        </subsection>
      </section>
    </body>
  </act>
</akomaNtoso>
